A byproduct of vitamin A disarms the immune system, allowing tumors to hide from its attack. This mechanism also weakens the effectiveness of cancer vaccines. Scientists have identified this pathway in preclinical studies. They have developed a drug that blocks it. This drug dramatically strengthens immune responses. At the same time, it slows down the growth of cancer.